Immunohistochemistry (IHC) was performed to evaluate KNSTRN expression in tumor and normal adjacent tissues (NAT) from TNBC patients and other breast cancer subtypes, as well as the correlation between KNSTRN expression and CD8+ T cell infiltration in TNBC. The gene discussed is CD8A; the disease is breast carcinoma.